Key Points- Merck reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. – The pharmaceutical giant posted a quarterly loss, however, due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.- The company also issued […]
